BVS
Bioventus
$13.06
−$0.57 (−4.18%)Sep 10, 2026
Key metrics
The numbers that frame BVS today
- Market cap
- $1.10B
- P/E (TTM)
- 20.2
- EV / FCF
- 14.0
- Gross margin
- 68.7%
- EV / Sales
- 2.3
- ROIC
- 13.1%
- Div yield
- 0%
- Debt / equity
- 1.1
- 52wk Low
- $6.26
- 52wk High
- $15.89
Growth
Revenue and earnings trend for BVS
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about BVS
Is Bioventus a good buy?
Yes. Bioventus has excellent quality and excellent momentum. Both signals support the setup. Growth looks excellent, which supports the long-term business case. We think Bioventus is selling at a low price.
What is the market capitalization of BVS?
Bioventus's market capitalization is $1.10B.
What is the P/E ratio for BVS stock?
Bioventus's current P/E ratio is 20.2.
What is the 52-week high for BVS stock?
The 52-week high for Bioventus is $15.89. The current close of $13.06 is 17.8% below that high.
What is the 52-week low for BVS stock?
The 52-week low for Bioventus is $6.26. The current close of $13.06 is 108.8% above that low.
Does BVS stock pay dividends?
Bioventus does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for BVS?
Bioventus's Debt / Equity ratio is 1.09.